erbstatin and Cell-Transformation--Viral

erbstatin has been researched along with Cell-Transformation--Viral* in 2 studies

Reviews

1 review(s) available for erbstatin and Cell-Transformation--Viral

ArticleYear
Inhibition of Abelson oncogene function by erbstatin analogues.
    Drugs under experimental and clinical research, 1993, Volume: 19, Issue:6

    The authors examined the effect of a tyrosine kinase inhibitor, erbstatin, and its analogues on abl oncogene functions. Erbstatin and its stable analogue methyl 2,5-dihydroxycinnamate (2,5-MeC) inhibited the growth of v-ablts-NIH3T3 cells at the permissive temperature (33 degrees C) at lower concentrations than at the non-permissive temperature (39 degrees C). 2,5-MeC inhibited the morphological transformation and the activation of v-abl tyrosine kinase by the temperature shift (39 degrees C to 33 degrees C) more effectively than erbstatin. Previously the authors reported that erbstatin induced erythroid differentiation of K562 human chronic myelogenous leukaemia cells, so they examined the effect of erbstatin analogues on the erythroid differentiation. Among eight erbstatin analogues studied, ethyl 2,5-dihydroxycinnamate induced erythroid differentiation of K562 cells most effectively. Ethyl 2,5-dihydroxycinnamate also inhibited bcr-abl tyrosine kinase. These results indicate that the stable analogues of erbstatin suppress oncogene functions of Abl by inhibiting its tyrosine kinase.

    Topics: Abelson murine leukemia virus; Animals; Cell Differentiation; Cell Line, Transformed; Cell Survival; Cell Transformation, Viral; Cinnamates; Genes, abl; Humans; Hydroquinones; Oncogene Proteins v-abl; Protein-Tyrosine Kinases

1993

Other Studies

1 other study(ies) available for erbstatin and Cell-Transformation--Viral

ArticleYear
Induction of morphological change by tyrosine kinase inhibitors in Rous sarcoma virus-transformed rat kidney cells.
    FEBS letters, 1991, Feb-11, Volume: 279, Issue:1

    Erbstatin and methyl 2,5-dihydroxycinnamate, related tyrosine kinase inhibitors, induced a morphological change in temperature-sensitive Rous sarcoma virus-transformed rat kidney (RSVts-NRK) that brought the cells close to the morphology of their normal counterpart. Erbstatin did not change the morphology of normal or Kirsten sarcoma virus-transformed rat kidney cells. Erbstatin also inhibited morphological transformation of RSVts-NRK cells induced by a shifting in temperature. Actin stress fibres were observed only in normal cells and not in transformed cells. Erbstatin induced stress fibre organization in transformed cells. Erbstatin and methyl 2,5-dihydroxycinnamate increased fibronectin gene expression in RSV-transformed cells. Thus, tyrosine kinase inhibitors induced normal phenotypes specifically in v-src-expressing cells.

    Topics: Actins; Avian Sarcoma Viruses; Blotting, Northern; Cell Line, Transformed; Cell Transformation, Viral; Cinnamates; Fibronectins; Fluorescent Dyes; Gene Expression Regulation; Hydroquinones; Kidney; Nucleic Acid Hybridization; Protein-Tyrosine Kinases; RNA

1991